A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study

Publication | Open Access

DOI Full Paper Access

Citations

References

2016

Year

Sang‐Cheol Bae, Jinseok Kim, Jung‐Yoon Choe, Won Park, Sang‐Heon Lee, Yong‐Beom Park, Seung Cheol Shim, Shin‐Seok Lee, Yoon‐Kyoung Sung, Chan‐Bum Choi,

Annals of the Rheumatic Diseases